PHARMACOLOGY PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER EXAM
2026 WITH 100% ACCURATE ANSWERS
SECTION 1: PSYCHOPHARMACOLOGY – BASIC NEUROSCIENCE & MECHANISMS OF
ACTION (Q1–30)
1. A PMHNP is prescribing a medication that increases gamma-aminobutyric acid
(GABA) activity. Which clinical effect would the PMHNP expect?
A. Increased energy and focus
B. Calming, reduced anxiety, and sedation
C. Elevated mood and libido
D. Improved memory and cognition
Answer: B. Calming, reduced anxiety, and sedation
Rationale: GABA is the primary inhibitory neurotransmitter in the CNS. Increased
GABA activity reduces neuronal excitability, producing calming, anxiolytic, and
sedative effects. This is the mechanism of benzodiazepines and barbiturates.
,2. A patient with schizophrenia has been non-adherent to antipsychotics due to
severe weight gain and metabolic syndrome. Which medication is most likely to
cause these side effects?
A. Aripiprazole
B. Ziprasidone
C. Olanzapine
D. Lurasidone
Answer: C. Olanzapine
Rationale: Olanzapine (Zyprexa) is associated with the highest risk of weight gain,
increased waist circumference, dyslipidemia, and metabolic syndrome among
atypical antipsychotics. Aripiprazole and ziprasidone have the least metabolic side
effects.
3. The PMHNP is reviewing genetic testing results for a patient starting an
antidepressant. The results show the patient is a CYP2D6 poor metabolizer. Which
medication requires caution?
A. Sertraline
B. Escitalopram
,C. Fluoxetine
D. Vortioxetine
Answer: C. Fluoxetine
Rationale: Fluoxetine and paroxetine are potent CYP2D6 inhibitors. In a poor
metabolizer, drug levels can become toxic. CYP2D6 metabolizes many
psychotropics, and genetic testing helps guide dosing.
4. A patient asks, "Why does my antidepressant take weeks to work if it increases
serotonin right away?" The PMHNP explains that the delayed response is due to:
A. Slow absorption from the GI tract
B. Signal transduction cascades and downstream effects
C. First-pass metabolism in the liver
D. Protein binding displacement
Answer: B. Signal transduction cascades and downstream effects
Rationale: While neurotransmitter levels change within hours, clinical response
requires downstream intracellular signaling, gene expression changes, and
synaptic remodeling—processes that take weeks to fully develop.
, 5. Which statement correctly describes the role of glutamate in psychiatric
disorders?
A. Low glutamate is associated with mania
B. High glutamate is associated with schizophrenia, epilepsy, and mania
C. Glutamate has no role in psychiatric illness
D. Glutamate only affects movement disorders
Answer: B. High glutamate is associated with schizophrenia, epilepsy, and mania
Rationale: Glutamate is the brain's primary excitatory neurotransmitter. Excessive
glutamate activity via NMDA receptors is implicated in schizophrenia, seizure
disorders, and manic states. Memantine (NMDA antagonist) is used in
Alzheimer's.
6. A patient with bipolar disorder is started on valproic acid. Before initiating
therapy, which lab is most important to obtain?
A. CBC with differential
B. Liver function tests
2026 WITH 100% ACCURATE ANSWERS
SECTION 1: PSYCHOPHARMACOLOGY – BASIC NEUROSCIENCE & MECHANISMS OF
ACTION (Q1–30)
1. A PMHNP is prescribing a medication that increases gamma-aminobutyric acid
(GABA) activity. Which clinical effect would the PMHNP expect?
A. Increased energy and focus
B. Calming, reduced anxiety, and sedation
C. Elevated mood and libido
D. Improved memory and cognition
Answer: B. Calming, reduced anxiety, and sedation
Rationale: GABA is the primary inhibitory neurotransmitter in the CNS. Increased
GABA activity reduces neuronal excitability, producing calming, anxiolytic, and
sedative effects. This is the mechanism of benzodiazepines and barbiturates.
,2. A patient with schizophrenia has been non-adherent to antipsychotics due to
severe weight gain and metabolic syndrome. Which medication is most likely to
cause these side effects?
A. Aripiprazole
B. Ziprasidone
C. Olanzapine
D. Lurasidone
Answer: C. Olanzapine
Rationale: Olanzapine (Zyprexa) is associated with the highest risk of weight gain,
increased waist circumference, dyslipidemia, and metabolic syndrome among
atypical antipsychotics. Aripiprazole and ziprasidone have the least metabolic side
effects.
3. The PMHNP is reviewing genetic testing results for a patient starting an
antidepressant. The results show the patient is a CYP2D6 poor metabolizer. Which
medication requires caution?
A. Sertraline
B. Escitalopram
,C. Fluoxetine
D. Vortioxetine
Answer: C. Fluoxetine
Rationale: Fluoxetine and paroxetine are potent CYP2D6 inhibitors. In a poor
metabolizer, drug levels can become toxic. CYP2D6 metabolizes many
psychotropics, and genetic testing helps guide dosing.
4. A patient asks, "Why does my antidepressant take weeks to work if it increases
serotonin right away?" The PMHNP explains that the delayed response is due to:
A. Slow absorption from the GI tract
B. Signal transduction cascades and downstream effects
C. First-pass metabolism in the liver
D. Protein binding displacement
Answer: B. Signal transduction cascades and downstream effects
Rationale: While neurotransmitter levels change within hours, clinical response
requires downstream intracellular signaling, gene expression changes, and
synaptic remodeling—processes that take weeks to fully develop.
, 5. Which statement correctly describes the role of glutamate in psychiatric
disorders?
A. Low glutamate is associated with mania
B. High glutamate is associated with schizophrenia, epilepsy, and mania
C. Glutamate has no role in psychiatric illness
D. Glutamate only affects movement disorders
Answer: B. High glutamate is associated with schizophrenia, epilepsy, and mania
Rationale: Glutamate is the brain's primary excitatory neurotransmitter. Excessive
glutamate activity via NMDA receptors is implicated in schizophrenia, seizure
disorders, and manic states. Memantine (NMDA antagonist) is used in
Alzheimer's.
6. A patient with bipolar disorder is started on valproic acid. Before initiating
therapy, which lab is most important to obtain?
A. CBC with differential
B. Liver function tests
